IP Library Granted Patent US 12,263,255
Granted Patent B2
US 12,263,255 · App. 16/218,197 · Granted Apr 1, 2025

Debriding wound dressing, process of manufacture and useful articles thereof

Inventors: Mark E. Dillon (Center Valley, PA); Krishna Narayanan (Pittsburgh, PA); Sean Michael Adams (Allentown, PA)
Assignee: Bio Med Sciences, Inc.
A61L15/38A61F13/00063A61F13/05A61F13/069A61F13/15699A61F13/36A61F13/51113A61F13/51121A61L15/225A61L15/26A61L15/425A61L15/44A61F2013/00089A61F2013/530226A61F2013/530802A61L2300/254A61L2300/40A61L2400/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,263,255
App. No.
16/218,197
Granted
Apr 1, 2025
Kind
B2
Abstract

A wound dressing for active continuous debridement of devitalized tissues in non-healing wounds including diabetic ulcers, pressure ulcers, burn injuries and other etiologies, includes an active ingredient, such as collagenase, which serves to debride wounds in-situ. In one example, purified Collagenase (90% pure) was deposited onto several wound dressing materials. A key feature of this invention is that the activity level of the Collagenase used was substantially preserved.

Claims (48)

1. A wound dressing for active continuous debridement of devitalized tissues in non-healing wounds, comprising

a substrate, the substrate having a non-adherent wound contacting layer having a wound contacting side, the non-adherent wound contacting layer comprising only silicone,

the wound dressing having a wound contacting surface, the wound contacting side of the non-adherent wound contacting layer comprising the entire wound contacting surface of the wound dressing, and

a coating of an effective amount of an enzymatic debriding agent on and being in direct contact with the wound contacting side of the non-adherent wound contacting layer,

the enzymatic debriding agent being collagenase, and

the collagenase being 90% pure collagenase, and the collagenase on the wound contacting side of the non-adherent wound contacting layer having a coating weight of 1.31 mg/square centimeter.

2. The wound dressing of claim 1 ,

the substrate comprising a polyester non-woven mesh coated with silicone on one side, and

the silicone comprising the non-adherent wound contacting layer.

3. The wound dressing of claim 1 ,

the substrate comprising a polyester non-woven mesh coated on both sides with silicone, and

the silicone on either side of the polyester non-woven mesh comprising the non-adherent wound contacting layer.

4. A wound dressing for active continuous debridement of devitalized tissues in non-healing wounds, comprising

a substrate, the substrate having a non-adherent wound contacting layer having a wound contacting side, the non-adherent wound contacting layer comprising only silicone,

the wound dressing having a wound contacting surface, the wound contacting side of the non-adherent wound contacting layer comprising the entire wound contacting surface of the wound dressing, and

a dusting of an effective amount of an enzymatic debriding agent on and being in direct contact with the wound contacting side of the non-adherent wound contacting layer,

the enzymatic debriding agent being collagenase, and

the collagenase being 90% pure collagenase, and the collagenase on the wound contacting side of the non-adherent wound contacting layer having a coating weight of 1.31 mg/square centimeter.

5. The wound dressing of claim 4 ,

the substrate comprising a polyester non-woven mesh coated with silicone on one side, and

the silicone comprising the non-adherent wound contacting layer.

6. The wound dressing of claim 4 ,

the substrate comprising a polyester non-woven mesh coated on both sides with silicone, and

the silicone on either side of the polyester non-woven mesh comprising the non-adherent wound contacting layer.

7. A wound dressing for active continuous debridement of devitalized tissues in non-healing wounds, comprising

a substrate, the substrate having a wound contacting surface, and the wound contacting surface of the substrate comprising only silicone, and

a dusting on the wound contacting surface of the substrate of an effective amount of an enzymatic debriding agent, and

the enzymatic debriding agent being collagenase,

wherein the collagenase is 90% pure collagenase, and wherein the collagenase on the substrate has a coating weight of 1.31 mg/square centimeter.

8. The wound dressing of claim 7 ,

the substrate comprising a polyester non-woven mesh coated with silicone on one side.

9. The wound dressing of claim 7 ,

the substrate comprising a polyester non-woven mesh coated on both sides with silicone.

10. A wound dressing for active continuous debridement of devitalized tissues in non-healing wounds, comprising

a substrate, the substrate having a wound contacting surface, and the wound contacting surface of the substrate comprising only silicone, and

a coating on the wound contacting surface of the substrate of an effective amount of an enzymatic debriding agent, and

the enzymatic debriding agent being collagenase,

wherein the collagenase is 90% pure collagenase, and wherein the collagenase on the substrate has a coating weight of 1.31 mg/square centimeter.

11. The wound dressing of claim 10 ,

the substrate comprising a polyester non-woven mesh coated with silicone on one side.

12. The wound dressing of claim 10 ,

the substrate comprising a polyester non-woven mesh coated on both sides with silicone.

13. A wound dressing for active continuous debridement of devitalized tissues in non-healing wounds, comprising

a non-adherent wound contacting layer having a wound contacting side,

the non-adherent wound contacting layer comprising only silicone, and

the wound contacting side of the non-adherent wound contacting layer having an effective amount of an enzymatic debriding agent on and in direct contact with the wound contacting side of the non-adherent wound contacting layer,

the enzymatic debriding agent being collagenase,

the collagenase being 90% pure collagenase, and the collagenase on the wound contacting side of the non-adherent wound contacting layer having a coating weight of 1.31 mg/square centimeter.

Assignments (5)
NUNC PRO TUNC ASSIGNMENT Recorded Aug 20, 2019
From: ADAMS, SEAN MICHAEL
To: BIO MED SCIENCES, INC.
Reel/Frame 050098/0481 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 20, 2019
From: DILLON, MARK E; NARAYANAN, KRISHNA, DR
To: BIO MED SCIENCES, INC.
Reel/Frame 050106/0256 →
NUNC PRO TUNC ASSIGNMENT Recorded Aug 20, 2019
From: ADAMS, SEAN MICHAEL
To: BIO MED SCIENCES, INC.
Reel/Frame 050106/0318 →
MERGER Recorded Aug 20, 2019
From: BIO MED SCIENCES, INC.
To: BIO MED SCIENCES, INC.
Reel/Frame 050106/0707 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 6, 2019
From: DILLON, MARK E; NARAYANAN, KRISHNA, DR
To: BIO MED SCIENCES, INC.
Reel/Frame 048514/0426 →
Continuity (2)
Provisional Application 62597798 · Dec 12, 2017
Related Publication 20190192724A1 · Jun 27, 2019
References Cited (22)
US 3339546A · Chen · 1967 [cited by examiner]
US 3705083A · Wegman · 1972 [cited by examiner]
US 4832009A · Dillon · 1989 [cited by applicant]
US 5759560A · Dillon · 1998 [cited by applicant]
US 20010024656A1 · Dillon · 2001 [cited by applicant]
US 20020156437A1 · McDevitt et al. · 2002 [cited by applicant]
US 20050159695A1 · Cullen et al. · 2005 [cited by applicant]
US 20060083776A1 · Bott · 2006 [cited by examiner]
US 20070265585A1 · Joshi et al. · 2007 [cited by applicant]
US 20110251574A1 · Hedrich et al. · 2011 [cited by applicant]
US 20140114268A1 · Auguste · 2014 [cited by examiner]
US 20140322512A1 · Pham · 2014 [cited by examiner]
EP 0290207A2 · 1988 [cited by examiner]
FR 2975710A1 · 2012 [cited by examiner]
Lighthouse Medical Supplies (“What is the Difference Between Woven and Nonwoven Gauze?”) (Year: 2019). [cited by examiner]
Machine translation of FR-2975710-A1 (Year: 2012). [cited by examiner]
Machine translation of EP 0290207 A2 (Year: 1988). [cited by examiner]
International Search Report (copy enclosed) and Search Strategy (4 pages—copy enclosed), PCT Appln No. PCT/US2018/65263. [cited by applicant]
Written Opinion of the International Searching Authority (copy enclosed), PCT Appln. No. PCT/US2018/65263. [cited by applicant]
“What is the difference between woven and non-woven gauze?” (Lighthouse Medical Supplies Ltd) Sep. 20, 2016. [cited by applicant]
International Search Report and Search Strategy. [cited by applicant]
Written Opinion of the International Searching Authority. [cited by applicant]